Postoperative adjuvant lapatinib and concurrent chemoradiotherapy followed by maintenance lapatinib monotherapy in high-risk patients with resected squamous cell carcinoma of the head and neck: A phase III, randomized, double-blind, placebo-controlled study - Harrington, K; Temam, S; Mehanna, H (Journal of Clinical Oncology, 2015)
. doi:10.1200/JCO.2015.61.4370